Your browser doesn't support javascript.
loading
Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency.
Cereser, Lorenzo; De Carli, Riccardo; Girometti, Rossano; De Pellegrin, Alessandro; Reccardini, Federico; Frossi, Barbara; De Carli, Marco.
Affiliation
  • Cereser L; Department of Medicine, Institute of Radiology, University of Udine, Udine, Italy.
  • De Carli R; Department of Health Sciences, Tumor Immunology Unit, University of Palermo, Palermo, Italy.
  • Girometti R; Department of Medicine, Institute of Radiology, University of Udine, Udine, Italy.
  • De Pellegrin A; Department of Pathology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Reccardini F; Department of Pneumology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Frossi B; Department of Medicine, University of Udine, Udine, Italy.
  • De Carli M; Second Unit of Internal Medicine, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy. Electronic address: decarli.marco@libero.it.
J Allergy Clin Immunol Pract ; 7(3): 1055-1057.e2, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30408616

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Common Variable Immunodeficiency / Lung Diseases, Interstitial / Rituximab / Immunologic Factors Limits: Adult / Female / Humans / Male Language: En Journal: J Allergy Clin Immunol Pract Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Common Variable Immunodeficiency / Lung Diseases, Interstitial / Rituximab / Immunologic Factors Limits: Adult / Female / Humans / Male Language: En Journal: J Allergy Clin Immunol Pract Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United States